brentuximab
seagen
['lymphoma']
great presentation by dr kerry savage on management of peripheral t cell lymphoma. key takeaways include the improvement in pfs and os with chp-bv compared to chop as well as future studies which look to integrate novel agents into chop #asco23 
Heme/Onc Fellow @ClevelandClinic| Proud @PittTweet, @WakeForestMed and @OhioStateIMRes Alum| Opinions Are My Own| Most Tweets Will Involve Soccer